Clinical Trials in Taipei, Zhongzheng
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)
Ovarian NeoplasmsUterine Cervical NeoplasmsEndometrial Neoplasms+3 more
Yonsei University198 enrolled27 locationsNCT06023862
Recruiting
Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia
Rare Malignant Neoplasm
National Cancer Center, Japan1,000 enrolled18 locationsNCT05217407